NDC codes

404917 NDC codes with hospital pricing data in the network.

• NDC 63323-0705-08 — Ampicillin sodium injection, 500 mgAI (22 hospitals, 46–298 samples)
• NDC 00781-3408-02 — INJECTION, AMPICILLIN SODIUM, 500 MG (8 hospitals, 46–298 samples)
• NDC 00409-3719-10 — Ampicillin 250 mg injection solutionAI (43 hospitals, 46–298 samples)
• NDC 71288-0114-50 — Gemcitabine IV injection, 1 g vialAI (286 hospitals, 135–297 samples)
• NDC 00143-9888-01a — amoxicillin 125 mg/5 mL Oral Susp 5 mL (4 hospitals, 216–297 samples)
• NDC 13533-0703-10 — Alpha-1 proteinase inhibitor injection powderAI (79 hospitals, 243–297 samples)
• NDC 71288-0032-91 — Ampicillin-sulbactam 3 gram injectionAI (76 hospitals, 90–297 samples)
• NDC 13533-0700-01 — Alpha-1 proteinase inhibitor injectionAI (33 hospitals, 243–297 samples)
• NDC 13533-0701-01 — Alpha-1 proteinase inhibitor injection, 10 mgAI (16 hospitals, 243–297 samples)
• NDC 09920-0004-59 — MORPHINE 0.5 MG/ML INFUSION DRIP (9 hospitals, 63–297 samples)
• NDC 09920-0005-03 — MORPHINE SULFATE PCA 1 MG/ML IV SOLN (9 hospitals, 63–297 samples)
• NDC 24987-0260-10 — Digoxin injection 250 mcg per mL, 2 mL vialAI (113 hospitals, 80–296 samples)
• NDC 50458-0562-01 — Paliperidone palmitate 117 mg injection syringeAI (533 hospitals, 251–296 samples)
• NDC 66794-0156-01 — Intrathecal baclofen 20 mg/20 mL syringeAI (217 hospitals, 197–296 samples)
• NDC 70515-0263-10 — Digoxin 0.1 mg/mL injectionAI (307 hospitals, 80–296 samples)
• NDC 42023-0188-10 — Neostigmine injection 0.5 mg/mL, 10 mL vialAI (59 hospitals, 215–296 samples)
• NDC 71288-0303-91 — Vitamin B12 injection solutionAI (99 hospitals, 62–296 samples)
• NDC 70000-0661-01 — Magnesium citrate oral solutionAI (30 hospitals, 296 samples)
• NDC 80777-0113-87 — COVID-19 vaccine (Moderna) injection for ages 6 months to 11 yearsAI (30 hospitals, 260–296 samples)
• NDC 00000-6009-02 — ED TO GO-PERCOCET 2 TABLETS/PACK (5 hospitals, 170–296 samples)
• NDC 63323-0597-10 — Deferoxamine mesylate 500 mg injection vialAI (819 hospitals, 223–295 samples)
• NDC 00052-0602-01 — BCG live intravesical bladder instillationAI (108 hospitals, 178–295 samples)
• NDC 13533-0800-13 — Immune globulin 10% injection solutionAI (135 hospitals, 115–295 samples)
• NDC 00407-0690-15 — Gadodiamide contrast injection for imagingAI (64 hospitals, 133–295 samples)
• NDC 781311390 — Piperacillin-tazobactam antibiotic injection, 3.375 g vialAI (60 hospitals, 61–295 samples)
• NDC 781311491 — Piperacillin-tazobactam injection, 4.5 gram vialAI (63 hospitals, 61–295 samples)
• NDC 70092-9400-43 — Fentanyl injection in sodium chloride syringeAI (36 hospitals, 223–295 samples)
• NDC 73177-0103-28 — fentaNYL for continuous IV Set (5 hospitals, 223–295 samples)
• NDC CHCO1-9000-49 — FENTANYL CITRATE 5 MCG/ML DILUTION FOR ALLERGY SKIN TESTING (1 hospital, 223–295 samples)
• NDC 61553-0350-65 — fentaNYL Citrate 100 MCG/2ML Sosy 10 mL Syringe (3 hospitals, 223–295 samples)
• NDC CHCO1-9909-78 — FENTANYL CITRATE-NACL 10-0.9 MCG/ML-% IV SOL PFIL SYR (1 hospital, 223–295 samples)
• NDC CHCO1-9910-22 — BUPIVACAINE PF 0.082%,FENTANYL 2 MCG/ML PROGRAMMED INTERMITTENT BOLUS (1 hospital, 223–295 samples)
• NDC 55150-0180-03 — Amiodarone injection, 50 mg/mL vialAI (185 hospitals, 60–294 samples)
• NDC 55111-0652-07 — Bivalirudin 250 mg IV powderAI (237 hospitals, 60–294 samples)
• NDC 55111-0652-37 — Bivalirudin injection powder (250 mg, IV)AI (279 hospitals, 60–294 samples)
• NDC 59572-0102-01 — Azacitidine 100 mg vialAI (501 hospitals, 213–294 samples)
• NDC 63323-0508-25 — Meropenem 1 gram intravenous injectionAI (214 hospitals, 69–294 samples)
• NDC 72572-0140-01 — Diazepam 5 mg/mL injectionAI (114 hospitals, 96–294 samples)
• NDC 16729-0426-05 — Gemcitabine hydrochloride IV solution, 2 g per 20 mLAI (120 hospitals, 96–294 samples)
• NDC 63323-0325-24 — Acyclovir sodium injection, intravenous solutionAI (200 hospitals, 186–294 samples)
• NDC 00004-0263-01 — torsemide 10 mg Tab (6 hospitals, 249–294 samples)
• NDC 00024-0654-01 — Sarclisa (isatuximab) 100 mg IV infusion vialAI (553 hospitals, 249–294 samples)
• NDC 00869-0602-43 — Magnesium sulfate powder, 454 gAI (153 hospitals, 267–294 samples)
• NDC 16714-0981-01 — Medroxyprogesterone 150 mg/mL injectable suspensionAI (64 hospitals, 78–294 samples)
• NDC 65293-0001-01 — Bivalirudin 250 mg IV powderAI (130 hospitals, 60–294 samples)
• NDC 182844789 — Acetaminophen 325 mg tabletAI (22 hospitals, 105–294 samples)
• NDC 00409-1463-71 — Nalbuphine hydrochloride 10 mg/mL injectionAI (422 hospitals, 42–294 samples)
• NDC 65219-0120-12 — Dalbavancin injection, 500 mg vialAI (136 hospitals, 96–294 samples)
• NDC 409230504 — Midazolam injection, 1 mg per mLAI (48 hospitals, 96–294 samples)
• NDC 409259615 — Midazolam 5 mg/mL injectionAI (22 hospitals, 96–294 samples)